Pfizer said Friday it filed a lawsuit against Metsera and Novo Nordisk saying Metsera breached its merger agreement obligations.
In this article
Pfizer
said on Friday it had filed a lawsuit against Metsera
and Novo Nordisk
saying Metsera breached its merger agreement obligations in declaring the Danish drugmaker’s $8.5 billion bid for the U.S. obesity drug developer to be a superior offer.
Pfizer fa causa a Novo Nordisk sull’acquisizione di Metsera. “Controfferta viola accordi”
Novo Nordisk bids $9bn for obesity drug maker Metsera in challenge to Pfizer
Pfizer lleva a los tribunales la guerra de opa con Novo Nordisk por la ‘start-up’ de moda en el adelgazamiento
Guerra de opa en el adelgazamiento: Novo Nordisk supera a Pfizer con su oferta por Metsera
The Multi-Billion-Dollar Battle For Metsera
Pfizer files second lawsuit to block Novo Nordisk’s $9bn Metsera bid
Battle for obesity biotech Metsera heats up as Pfizer sues to block rival bid
Novo Nordisk rilancia l’offerta su Metsera a 10 miliardi di dollari
Más tensión en Novo Nordisk: rebaja previsiones en plena guerra con Pfizer por la ‘start-up’ de moda en el adelgazamiento
US regulator warns Novo Nordisk’s Metsera offer ‘may violate’ antitrust law
